NCT02807142View on ClinicalTrials.gov

Efficacy Assessment of the Cell Therapy Medicine NC1 in Patients With Post-traumatic Syringomyelia

PHASE2CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

March 31, 2016

Primary Completion Date

February 7, 2018

Study Completion Date

February 7, 2018

Conditions
Post-Traumatic Syringomyelia
Interventions
BIOLOGICAL

NC 1 cell therapy

All patients will be treated with NC1

All Listed Sponsors
lead

Puerta de Hierro University Hospital

OTHER

NCT02807142 - Efficacy Assessment of the Cell Therapy Medicine NC1 in Patients With Post-traumatic Syringomyelia | Biotech Hunter | Biotech Hunter